Exercise-Induced Bronchoconstriction

Exercise-Induced Bronchoconstriction

ACAAI/AAAAI Exercise-Induced Bronchoconstriction GUIDELINES Apps brought to you courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/102833

Contents of this Issue

Navigation

Page 7 of 9

Therapy Table 1. FDA-approved Drugs for EIB Drug (Brand) Dosage Form Dose Nebulizer solution Albuterol (Ventolin Nebules®, Accuneb®) 0.63 mg (0.021%) to 2-12 yrs: 0.63-1.25 mg tid - qid 1.25 mg (0.042%) per 3 mL over 5-15 mins Max dose: 2.5 mg MDI Albuterol (ProAir HFA®, Proventil HFA®, Ventolin HFA®) 120 mcg/dose ≥ 4 yrs: 2 inh 15-30 min before exercise Levalbuterol (Xopenex HFA®) 45 mcg/inh ≥ 4 yrs: 2 inh q4-6h prn, in some patients, 1 inh q4h may be sufficient Formoterol* (Foradil Aerolizer®) DPI: 12 mcg/single use capsule ≥ 5 yr: 1 capsule ≥ 15 mins before exercise, repeat ≥ 12 hr Salmeterol* (Serevent Diskus®) DPI: 50 mcg/blister ≥ 4 yr: 1 inh ≥ 30 mins before exercise, repeat ≥ 12 hr 10 mg tablet ≥ 15 yr: 10 mg ≥ 2 hr before exercise NEBULIZER: 20 mg/2 mL ampule 2 inh 10 to 15 minutes but not more than 60 minutes before exposure Long-acting β2-agonists Leukotriene modifiers Montelukast (Singulair®) Others Cromolyn (Generics) * BLACK BOX WARNING: Long-acting β2-adrenergic agonists may increase the risk of asthma-related death. They should never be used alone in children or adults with asthma. Please see product labeling for information on this warning. An FDA Medication Guide should be distributed to patients starting a new prescription.

Articles in this issue

Archives of this issue

view archives of Exercise-Induced Bronchoconstriction - Exercise-Induced Bronchoconstriction